Gene therapy in solid tumors: trends in trials in China and beyond

Kun Chen,Shuhang Wang,Bin Chen,Fa Sun,Ning Li

DOI: https://doi.org/10.1016/j.drudis.2020.09.014

IF: 8.369

2021-02-01

Drug Discovery Today

Abstract:<p>Gene therapy involves the introduction of new genes into cells, to modify or manipulate the expression of a gene or to alter the biological properties, for the purpose of treating disease. It is designed to treat genetic diseases at their root, by correcting the mutation responsible, its success in treatment of blood cancers and rare diseases is encouraging, and it is also beginning to show promising effects against solid tumors. Here, we comprehensively analyze all the active clinical trials of gene therapy for solid tumors from January 2010 to April 2020. Our analysis highlights the increasing trends in gene therapy trials in China and elsewhere, as well as the potential of oncolytic viruses as gene therapy products for solid tumors <em>in vivo</em>.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores the application trends of gene therapy in solid tumors, particularly focusing on the clinical trial situation in China and globally. Specifically, the paper aims to address the following key issues:

1. **Development trends of gene therapy**: Analyzing the active clinical trials on gene therapy for solid tumors worldwide from January 2010 to April 2020, including the classification of treatment methods (in vivo or ex vivo), vector systems (viral or non-viral), and paying attention to these trends in China.

2. **Characteristics of clinical trials**: Describing in detail the characteristics of these clinical trials, such as trial phase, status, primary endpoints, patient population, treatment line, disease stage, and the types of vectors used.

3. **Research situation in China**: Focusing particularly on gene therapy clinical trials conducted in China, including differences in registration and filing systems, distribution of trial types, and the studies registered in the China National Medical Products Administration (CDE) database.

4. **Application prospects of oncolytic viruses**: Evaluating the potential of oncolytic viruses as in vivo gene therapy products for solid tumors, discussing their mechanisms of action, clinical effects, and the challenges they face.

In summary, this paper aims to comprehensively analyze the research progress in the field of gene therapy for solid tumors, particularly the growth trends of gene therapy clinical trials in China and globally in recent years, with a focus on the development of oncolytic viruses as a promising therapeutic approach.